| |
Latest 10 SEC filings (by transaction date) for UTHR within the last 6 months | |
![]() ![]() |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -500 | $345.90 |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 ![]() | 2,500 | $111.00 |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -45 | $352.43 |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -720 | $349.90 |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -1,696 | $349.10 |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -3,697 | $347.98 |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -200 | $346.53 |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -1,142 | $345.69 |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Stock Options | M - Exercise or conversion exempt under rule 16b-3 ![]() | -7,500 | |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 ![]() | -2,500 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for UTHR within the last 6 months | |
![]() ![]() |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -500 | $345.90 |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 ![]() | 2,500 | $111.00 |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -45 | $352.43 |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -720 | $349.90 |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -1,696 | $349.10 |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -3,697 | $347.98 |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -200 | $346.53 |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -1,142 | $345.69 |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Stock Options | M - Exercise or conversion exempt under rule 16b-3 ![]() | -7,500 | |
Feb 11/25 | Feb 10/25 | Benkowitz Michael | Indirect Ownership | Stock Option | M - Exercise or conversion exempt under rule 16b-3 ![]() | -2,500 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Revolution Medicines (OQ:RVMD) |
CG Oncology (OQ:CGON) |
MBX Biosciences (OQ:MBX) |